NBW Capital’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

NBW Capital’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-35,229	Closed	-$2.62M	–	91
2022 Q2	$2.62M	Sell	35,229 -48,822	-58%	-$3.66M	0.72%	65
2022 Q1	$7.55M	Sell	84,051 -1,035	-1%	-$95.6K	1.79%	16
2021 Q4	$9.53M	Buy	85,086 +2,991	+4%	+$361K	2.12%	9
2021 Q3	$10.3M	Buy	82,095 +6,818	+9%	+$878K	2.49%	6
2021 Q2	$10.2M	Buy	75,277 +5,196	+7%	+$683K	2.48%	8
2021 Q1	$9.51M	Buy	70,081 +6,054	+9%	+$906K	2.62%	8
2020 Q4	$9.01M	Sell	64,027 -3,620	-5%	-$464K	2.74%	7
2020 Q3	$7.54M	Buy	67,647 +5,649	+9%	+$633K	2.51%	11
2020 Q2	$6.94M	Sell	61,998 -14,329	-19%	-$1.41M	2.49%	9
2020 Q1	$5.91M	Sell	76,327 -2,051	-3%	-$182K	2.82%	10
2019 Q4	$7.46M	Buy	78,378 +538	+0.7%	+$46.5K	2.12%	12
2019 Q3	$5.93M	Sell	77,840 -2,600	-3%	-$216K	1.76%	20
2019 Q2	$7.05M	Buy	80,440 +1,344	+2%	+$115K	1.94%	14
2019 Q1	$7.16M	Buy	79,096 +2,799	+4%	+$238K	1.96%	18
2018 Q4	$5.47M	Sell	76,297 -994	-1%	-$80.1K	1.94%	16
2018 Q3	$7.41M	Buy	77,291 +3,472	+5%	+$337K	1.99%	16
2018 Q2	$7.03M	Buy	73,819 +2,395	+3%	+$220K	2.01%	22
2018 Q1	$6.27M	Sell	71,424 -11,451	-14%	-$1.05M	1.96%	25
2017 Q4	$7.03M	Buy	82,875 +33,534	+68%	+$2.81M	1.85%	28
2017 Q3	$4.27M	Sell	49,341 -19	-0%	-$1.52K	1.16%	36
2017 Q2	$3.81M	Buy	+49,360	New	+$3.5M	1.06%	39

Other funds holding XBI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

NBW Capital's XBI Position: Q3 2022 in Review

NBW Capital sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2022, closing a stake of 35,229 shares — an estimated $2.62M sold.

NBW Capital first reported a position in XBI in Q2 2017 and held it in 21 quarters. The position peaked at $10.3M in Q3 2021. 704 funds tracked by Wall St. Rank hold XBI as of Q3 2022.

NBW Capital reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2022 after selling out during the quarter.
NBW Capital sold 35,229 State Street SPDR S&P Biotech ETF shares in Q3 2022, an estimated $2.62M.
NBW Capital first reported a position in State Street SPDR S&P Biotech ETF in Q2 2017 and held it in 21 quarters.
NBW Capital's State Street SPDR S&P Biotech ETF position peaked at $10.3M in Q3 2021.
704 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2022.

Based on NBW Capital's 13F filing for Q3 2022, filed 3 Nov 2022.